Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06757868
NA

Amobarbital and Cardiopulmonary Bypass

Sponsor: Tongji Hospital

View on ClinicalTrials.gov

Summary

Explore the effects of amobarbital on myocardial protection and prognosis in patients undergoing cardiac surgery with cardiopulmonary bypass, investigate the new usage of old drugs, and provide reliable clinical scientific basis for its potential value in better clinical treatment.

Official title: The Effect of Amobarbital on Myocardial Protection and Prognosis in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

80

Start Date

2025-02-01

Completion Date

2026-03-01

Last Updated

2025-03-21

Healthy Volunteers

No

Interventions

DRUG

Amobarbital

Amobarbital 1mg/kg is given prior to cardiopulmonary bypass

DRUG

Midazolam

midazolam 0.1mg/kg is given prior to cardiopulmonary bypass

Locations (1)

Tongji hospital

Wuhan, Hubei, China